Confirmation of the POLA Index and Its Association with COVID-19 and Influenza Incidence, Gut Microbiota, and Mucosal Immunity Markers in Young Women: A Pilot Cohort Study

Evidence for diet-driven immunomodulation remains limited in terms of practical tools. This pilot study prospectively evaluated the dietary POLA index in 51 women aged 25–45 years and living in Kraków, Poland. At baseline (2022), 7-day dietary intake and physical activity were recorded; stool samples were analyzed for gut microbiota composition; short-chain fatty acids were quantified using high-performance liquid chromatography; and fecal secretory IgA (sIgA), human β-defensin-2 (HBD-2), and calprotectin levels were measured by the enzyme-linked immuno-sorbent assay. In June 2023, post-baseline incidence of COVID-19 and influenza was self-reported. Participants were categorized into a group with beneficial immunomodulation (BIM, POLA score ≤ 5) and a group with unbeneficial/highly unbeneficial immunomodulation (UBIM + HUBIM, POLA score > 5). The incidence of COVID-19 or influenza was 7.7% (1/13) in the BIM group vs. 36.8% (14/38) in the UBIM + HUBIM group. After adjusting for age and smoking, the UBIM + HUBIM group had higher odds of infection compared with the BIM group (adjusted OR = 6.53; 95% CI: 1.02–129.85), corresponding to a higher absolute risk of 47.9% (95% CI 26.1–70.6) versus 12.3% (95% CI 1.4–58.1). The BIM group more often met the fiber and micronutrient adequacy targets and showed a higher proportion of sIgA levels within the reference range (92.3% vs. 60.5%), along with lower fecal succinic acid concentrations (median 3.27 mg/g vs. 4.32 mg/g). In this cohort, a favorable POLA score was associated with lower self-reported COVID-19 or influenza incidence and an sIgA profile suggestive of intestinal immune homeostasis. As this pilot study is underpowered, findings should be interpreted as exploratory and hypothesis-generating. Nonetheless, results support the POLA index as a practical diet-quality metric with potential immunomodulatory relevance.

Authors

Institutions

Publication Details

Journal
Applied Sciences
Published
2025-12-17
DOI
https://doi.org/10.3390/app152413237
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Confirmation of the POLA Index and Its Association with COVID-19 and Influenza Incidence, Gut Microbiota, and Mucosal Immunity Markers in Young Women: A Pilot Cohort Study

Paweł Basiukiewicz, Agnieszka Ostachowska-Gąsior, Paweł Jagielski, Paweł Kawalec et al.
Applied Sciences
Gut microbiota and health
article

Confirmation of the POLA Index and Its Association with COVID-19 and Influenza Incidence, Gut Microbiota, and Mucosal Immunity Markers in Young Women: A Pilot Cohort Study

Paweł Basiukiewicz, Agnieszka Ostachowska-Gąsior, Paweł Jagielski, Paweł Kawalec, Agnieszka Galanty, Agnieszka Micek, Justyna Dobrowolska‐Iwanek, Dominika Wnęk, Edyta Łuszczki, Anna Gąsior
article en

Abstract

Evidence for diet-driven immunomodulation remains limited in terms of practical tools. This pilot study prospectively evaluated the dietary POLA index in 51 women aged 25–45 years and living in Kraków, Poland. At baseline (2022), 7-day dietary intake and physical activity were recorded; stool samples were analyzed for gut microbiota composition; short-chain fatty acids were quantified using high-performance liquid chromatography; and fecal secretory IgA (sIgA), human β-defensin-2 (HBD-2), and calprotectin levels were measured by the enzyme-linked immuno-sorbent assay. In June 2023, post-baseline incidence of COVID-19 and influenza was self-reported. Participants were categorized into a group with beneficial immunomodulation (BIM, POLA score ≤ 5) and a group with unbeneficial/highly unbeneficial immunomodulation (UBIM + HUBIM, POLA score > 5). The incidence of COVID-19 or influenza was 7.7% (1/13) in the BIM group vs. 36.8% (14/38) in the UBIM + HUBIM group. After adjusting for age and smoking, the UBIM + HUBIM group had higher odds of infection compared with the BIM group (adjusted OR = 6.53; 95% CI: 1.02–129.85), corresponding to a higher absolute risk of 47.9% (95% CI 26.1–70.6) versus 12.3% (95% CI 1.4–58.1). The BIM group more often met the fiber and micronutrient adequacy targets and showed a higher proportion of sIgA levels within the reference range (92.3% vs. 60.5%), along with lower fecal succinic acid concentrations (median 3.27 mg/g vs. 4.32 mg/g). In this cohort, a favorable POLA score was associated with lower self-reported COVID-19 or influenza incidence and an sIgA profile suggestive of intestinal immune homeostasis. As this pilot study is underpowered, findings should be interpreted as exploratory and hypothesis-generating. Nonetheless, results support the POLA index as a practical diet-quality metric with potential immunomodulatory relevance.

Applied SciencesVol. 15(24)
Jagiellonian University (PL), MLabs (Poland) (PL), Cracow School of Health Promotion (PL), Western Hospital (AU), University of Rzeszów (PL)
Openalex Percentile: Top 63%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.